Substrate stress relaxation regulates neural stem cell fate commitment
Proceedings of the National Academy of Sciences · 09.07.2024 · 121 (28)
DOI: 10.1073/pnas.2317711121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 05.07.2024. Verfasst von Eric Qiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of California, Berkeley, CA 94720. Hauptthemen laut MEDLINE: Neural Stem Cells, Cell Differentiation. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS).
Abstract (Originalsprache)
Adult neural stem cells (NSCs) reside in the dentate gyrus of the hippocampus, and their capacity to generate neurons and glia plays a role in learning and memory. In addition, neurodegenerative diseases are known to be caused by a loss of neurons and glial cells, resulting in a need to better understand stem cell fate commitment processes. We previously showed that NSC fate commitment toward a neuronal or glial lineage is strongly influenced by extracellular matrix stiffness, a property of elastic materials. However, tissues in vivo are not purely elastic and have varying degrees of viscous character. Relatively little is known about how the viscoelastic properties of the substrate impact NSC fate commitment. Here, we introduce a polyacrylamide-based cell culture platform that incorporates mismatched DNA oligonucleotide-based cross-links as well as covalent cross-links. This platform allows for tunable viscous stress relaxation properties via variation in the number of mismatched base pairs. We find that NSCs exhibit increased astrocytic differentiation as the degree of stress relaxation is increased. Furthermore, culturing NSCs on increasingly stress-relaxing substrates impacts cytoskeletal dynamics by decreasing intracellular actin flow rates and stimulating cyclic activation of the mechanosensitive protein RhoA. Additionally, inhibition of motor–clutch model components such as myosin II and focal adhesion kinase partially or completely reverts cells to lineage distributions observed on elastic substrates. Collectively, our results introduce a unique system for controlling matrix stress relaxation properties and offer insight into how NSCs integrate viscoelastic cues to direct fate commitment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, University of California, Berkeley, CA 94720.
- Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720.
- Department of Bioengineering, University of California, Berkeley, CA 94720.
- Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143.
ORCID-Profile: Eric Qiao, Camille A Fulmore, David V Schaffer, Sanjay Kumar
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
Zitieren
APA
Qiao, E., Fulmore, C. A., Schaffer, D. V., & Kumar, S. (2024). Substrate stress relaxation regulates neural stem cell fate commitment. Proceedings of the National Academy of Sciences, 121(28). https://doi.org/10.1073/pnas.2317711121
Vancouver
Qiao E, Fulmore CA, Schaffer DV, Kumar S. Substrate stress relaxation regulates neural stem cell fate commitment. Proceedings of the National Academy of Sciences. 2024;121(28). doi:10.1073/pnas.2317711121
BibTeX
@article{Qiao2024,
author = {Qiao, Eric and Fulmore, Camille A and Schaffer, David V and Kumar, Sanjay},
title = {Substrate stress relaxation regulates neural stem cell fate commitment},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {28},
doi = {10.1073/pnas.2317711121}
}
EUVIMED